News und Analysen
Why PTC Therapeutics, Inc. Dropped Today
PTC Therapeutics (NASDAQ: PTCT) fell 10.9% on Tuesday after disclosing data for RG7916 in patients with Type 2 and Type 3 spinal muscular atrophy (SMA).It's been a roller coaster for PTC....
Intercept Pharmaceuticals, Inc. Was Halved in September, but Presents an Intriguing Opportunity
Shares of Intercept Pharmaceuticals (NASDAQ: ICPT), a small-cap biotech company with a focus on discovering medicines to treat non-viral, progressive liver diseases, lost roughly half of its value....
Why bluebird bio, Inc. Stock Gained 10% in September
Shares of bluebird bio, Inc. (NASDAQ: BLUE), a clinical-stage biotech developing cell-based therapies, rose 10% in September according to data from S&P Global Market Intelligence. Although....
Why bluebird bio, Inc. Stock Gained 10% in September
Shares of bluebird bio, Inc. (NASDAQ: BLUE), a clinical-stage biotech developing cell-based therapies, rose 10% in September according to data from S&P Global Market Intelligence. Although....
Why bluebird bio, Inc. Stock Gained 10% in September
Shares of bluebird bio, Inc. (NASDAQ: BLUE), a clinical-stage biotech developing cell-based therapies, rose 10% in September according to data from S&P Global Market Intelligence. Although....
Is This How Drugmakers Will Kill Biosimilars?
Pfizer (NYSE: PFE) has filed a lawsuit accusing Johnson & Johnson (NYSE: JNJ) of strong-arming insurers into excluding its Remicade biosimilar, Inflectra, from their reimbursement lists. If....
Is This How Drugmakers Will Kill Biosimilars?
Pfizer (NYSE: PFE) has filed a lawsuit accusing Johnson & Johnson (NYSE: JNJ) of strong-arming insurers into excluding its Remicade biosimilar, Inflectra, from their reimbursement lists. If....
After Intepirdine Flunked in Alzheimer’s Disease, Is Axovant Sciences a Buy?
Hope was running high at Axovant Sciences (NASDAQ: AXON) that that teaming up their drug intepirdine with the top-selling Alzheimer's disease treatment, Aricept, could improve patients' lives.....
After Intepirdine Flunked in Alzheimer’s Disease, Is Axovant Sciences a Buy?
Hope was running high at Axovant Sciences (NASDAQ: AXON) that that teaming up their drug intepirdine with the top-selling Alzheimer's disease treatment, Aricept, could improve patients' lives.....
After Intepirdine Flunked in Alzheimer’s Disease, Is Axovant Sciences a Buy?
Hope was running high at Axovant Sciences (NASDAQ: AXON) that that teaming up their drug intepirdine with the top-selling Alzheimer's disease treatment, Aricept, could improve patients' lives.....
Good News and Bad News for Gilead Sciences: Which Carries More Weight?
You knew it wouldn't take too long for euphoria over Gilead Sciences' (NASDAQ: GILD) planned acquisition of Kite Pharma to wear off. The question was whether the next round of news for the big....
Good News and Bad News for Gilead Sciences: Which Carries More Weight?
You knew it wouldn't take too long for euphoria over Gilead Sciences' (NASDAQ: GILD) planned acquisition of Kite Pharma to wear off. The question was whether the next round of news for the big....
Why AcelRx Pharmaceuticals Inc Jumped Higher Today
AcelRx Pharmaceuticals (NASDAQ: ACRX) closed up nearly 20% on Monday, having jumped a whopping 64% over the last week. While there's no apparent news today to drive the stock higher -- or within....
Why MannKind Corporation Popped Today
Shares of MannKind Corporation (NASDAQ: MNKD), a commercial-stage biopharma focused on inhaled insulin, rose as much as 13% in afternoon trading on Monday. Shareholders can largely thank two....
Sarepta Therapeutics Stock Soars Despite Adverse Event Worries
Late last week, some Sarepta Therapeutics (NASDAQ: SRPT) investors were worried. Now the weekend is over, and all of those worries seem to have dissipated.Concerns arose after the U.S. Food and....
3 Beaten-Down Biotech Stocks to Buy Right Now
Biotech stocks that crater on negative clinical results or unfavorable regulatory developments can sometimes represent outstanding investing opportunities. Not all beaten-down biotech stocks,....
Here's Why Rigel Pharmaceuticals, Inc. Is Jumping Higher Today
Shares of Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a clinical-stage biotech, are on the rise today after the company announced results of a recent meeting with the Food and Drug Administration.....
Why Seres Therapeutics Inc. Stock Is Tanking Today
Shares of Seres Therapeutics (NASDAQ: MCRB), a clinical-stage biotech focused on microbiome therapeutics, were down 19% as of 11:25 a.m. EDT on Monday. The decline can be traced to the release of....
AbbVie Stock Upgraded: What You Need to Know
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
AbbVie Stock Upgraded: What You Need to Know
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
AbbVie Stock Upgraded: What You Need to Know
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
Why Dynavax Technologies Corporation Stock Is Rising Today
Shares of Dynavax Technologies Corporation (NASDAQ: DVAX) are up by over 11% in pre-market trading on modest volume this morning, following a report that management is exploring different....
Better Buy: Gilead Sciences, Inc. vs. Pfizer
The biopharmaceutical industry has been exceptionally kind to investors over the past six years because of the introduction of several new classes of drugs, greater insurance coverage for....
Better Buy: Gilead Sciences, Inc. vs. Pfizer
The biopharmaceutical industry has been exceptionally kind to investors over the past six years because of the introduction of several new classes of drugs, greater insurance coverage for....
If You Love Intuitive Surgical, You Should Check Out Mazor Robotics
There's a whole lot of things to love about Intuitive Surgical (NASDAQ: ISRG). The company pioneered the use of robotic surgical systems. It has become very profitable along the way. And, of....